[1]杨华盛,黄恒炜,陈宇杰.绝经后骨质疏松症与人体成分指标相关性初探[J].中国中医骨伤科杂志,2023,31(12):34-37+42.[doi:10.20085/j.cnki.issn1005-0205.231207]
　YANG Huasheng,HUANG Hengwei,CHEN Yujie.Preliminary Study on the Correlation between Postmenopausal Osteoporosis and Body Composition Indicators[J].Chinese Journal of Traditional Medical Traumatology & Orthopedics,2023,31(12):34-37+42.[doi:10.20085/j.cnki.issn1005-0205.231207]
点击复制

绝经后骨质疏松症与人体成分指标相关性初探()
分享到：

《中国中医骨伤科杂志》[ISSN:1005-0205/CN:42-1340/R]

卷:
第31卷
期数:
2023年12期
页码:
34-37+42
栏目:
临床研究
出版日期:
2023-12-15

文章信息/Info

Title:
Preliminary Study on the Correlation between Postmenopausal Osteoporosis and Body Composition Indicators
文章编号:
1005-0205(2023)12-0034-04
作者:
杨华盛1; 黄恒炜1; 陈宇杰1
1福清市中医院老年医学科(福建 福清,350300)
Author(s):
YANG Huasheng1; HUANG Hengwei1; CHEN Yujie1
1 Fuqing Traditional Chines Medicine Hospital,Fuqing 350300,Fujian China.
关键词:
绝经后骨质疏松症;  肌肉量;  骨骼肌量
Keywords:
postmenopausal osteoporosis;  muscle mass;  skeletal muscle mass
分类号:
R274
DOI:
10.20085/j.cnki.issn1005-0205.231207
文献标志码:
A
摘要:
目的:探讨绝经后骨质疏松症(PMOP)与人体成分分析指标的关系,从而为绝经后骨质疏松症的防治提供指导。方法:福清地区绝经后女性受试者144例,分为骨质疏松症组78例、非骨质疏松症组66例。采用双能X线吸收测定法(DXA)检测骨密度,用人体成分分析仪测定人体成分,并通过调查问卷登记受试者基本信息。采用独立样本t检验分析,了解绝经后骨质疏松症与体脂肪率、肌肉量、骨骼肌量及肌肉分布的相关性。结果:根据人体成分分析检测统计骨质疏松症组肌肉量小于非骨质疏松症组(P=0.032),骨骼肌量小于非骨质疏松症组(P=0.011)。骨质疏松症组身高、体重、体重指数及体脂肪率和非骨质疏松症组差异无统计学意义(P>0.05)。骨质疏松症组的骨骼肌/身高平方小于非骨质疏松症组(P=0.033),骨骼肌/肌肉量小于非骨质疏松症组(P=0.006)。在门诊为主体的受试者中,骨质疏松症组下肢肌肉评价低于非骨质疏松症组(P=0.026)。骨质疏松症组体脂肪率、肌肉量/身高平方、上肢肌肉评价、躯干肌肉评价与非骨质疏松症组差异无统计学意义(P>0.05)。结论:绝经后骨质疏松症与年龄、绝经年龄、肌肉量、骨骼肌量、肌肉情况分布相关。
Abstract:
Objective:To explore the relationship between postmenopausal osteoporosis(PMOP)and body composition analysis indicators,in order to provide guidance for the prevention and treatment of postmenopausal osteoporosis.Methods:144 postmenopausal female subjects in Fuqing area were divided into an osteoporosis group of 78 cases and a non osteoporosis group of 66 cases.Dualenergy X-ray absorptiometry(DXA)method was used to detect bone mineral density,human body composition was measured by using a body composition analyzer,and basic information of the subjects was recorded through a survey questionnaire.Using independent sample t-test analysis to understand the correlation between postmenopausal osteoporosis and body fat rate,muscle mass,skeletal muscle mass,and muscle distribution.Results:According to the analysis of human body composition,the muscle mass of the osteoporosis group is smaller than that of the non osteoporosis group(P=0.032),and the skeletal muscle mass is smaller than that of the non osteoporosis group(P=0.011).There was no significant difference in height,weight,body mass index(BMI),and body fat percentage between the osteoporosis group and the non osteoporosis group(P>0.05).The skeletal muscle/height square of the osteoporosis group is smaller than that of the non osteoporosis group(P=0.033),and the skeletal muscle/muscle mass is smaller than that of the non osteoporosis group(P=0.006).Among the outpatient subjects,the evaluation of lower limb muscles in the osteoporosis group was lower than that in the non osteoporosis group(P=0.026).There was no significant difference in body fat rate,muscle mass/height square,upper limb muscle evaluation,trunk muscle evaluation between the osteoporosis group and the non osteoporosis group(P>0.05).Conclusion:Postmenopausal osteoporosis is related to age,menopausal age,muscle mass,skeletal muscle mass,and muscle condition distribution.

参考文献/References:

[1] PECK W.Consensus development conference:diagnosis,prophylaxis,and treatment of osteoporosis[J].Am J Med,1993,94(6):646-650.
[2] SANCHEZ-RODRIGUEZ D,MARCO E,CRUZ-JENTOFT A J.Defining sarcopenia:some caveats and challenges[J].Curr Opin Clin NutrMetab Care,2020,23(2):127-132.
[3] CRUZ-JENTOFT A J,SAYER A A.Sarcopenia[J].Lancet,2019,393(10191):2636-2646.
[4] BINKLEY N,KRUEGER D,BUEHRING B.What's in a name revisited:should osteoporpsis and sarcopenia be considered components of “dysmobility syndrone”?[J].Osteoporos Int,2013,24(12):2955-2959.
[5] GOMARASCA M,BANFI G,LOMBARDI G.Myokines:the endocrine coupling of skeletal muscle and bone[J].Adv Clin Chem,2020,94:155-218.
[6] 李佳蔚,周子一,于普林,等.肌少症诊断标准及其相关参数的研究进展[J].中华老年医学杂志,2022,41(7):867-871.
[7] 中国健康促进基金会肌少-骨质疏松症专家共识委员会.肌少-骨质疏松症专家共识[J].中国骨质疏松杂志,2022,28(11):1561-1570.
[8] LIANG-KUNG C,JEAN W,PRASERT A,et al.Asian working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Direct Assoc,2020,21(3):300-307.
[9] FINKELSTEIN J S,BROCKWELL S E,MEHTA V,et al.Bone mineral density changes during the menopause transition in a multiethnic cohort of women[J].J Clin Endocrinol Metab,2008,93(3):861-868.
[10] 中华医学会骨质疏松和骨矿盐疾病分会.原发性骨质疏松症诊疗指南(2022)[J].中国全科医学,2023,26(14):1671-1691.
[11] LASKOU F,PATEL H P,COOPER C,et al.A pas de deux of osteoporosis and sarcopenia:osteosarcopenia[J].Climacteric,2022,25(1):88-95.
[12] 古玲珑,杨文怡.少肌症与动脉粥样硬化的相关性研究进展[J].中西医结合心血管病电子杂志,2020,8(19):13.
[13] BIJLSMA A Y,MESKERS M C G,MOLENDIJK M,et al.Diagnostic measures for sarcopenia and bone mineral density[J].Osteoporos Int,2013,24(10):2681-2691.
[14] LAI C L,TSENG S Y,CHEN C N,et al,Effect of 6 months of whole body vibration on lumbar spine bone density in postmenopausal women:a randomized controlled trial[J].Clin Interv Aging,2013,8:1603-1609.
[15] 李青梅,潘明明,冯燕,等.生活方式对骨密度影响的研究进展[J].中国中医骨伤科杂志,2016,24(8):80-82.
[16] PAPADOPOULOU S K,PAPADIMITRIOU K,VOULGARIDOU G,et al.Exercise and nutrition impact on osteoporosis and sarcopenia-the incidence of osteosarcopenia:a narrative review[J].Nutients,2021,13(12):4499.
[17] 胡志俊,闵文,赵长伟.中西医结合治疗骨量减少专家共识[J].中国中医骨伤科杂志,2023,31(2):78-83.
[18] RINONAPOLI G,PACE V,RUGGIERO C,et al.Obesity and bone:a complex relationship[J].Int J Mol Sci,2021,22(24):13662.
[19] 王杰,杨宝辉,李浩鹏.骨质疏松性腰椎椎体压缩性骨折的危险因素分析[J].中国中医骨伤科杂志,2021,29(8):29-33.

备注/Memo

备注/Memo:
基金项目:福建省中西医结合防治骨质疏松重点实验室(福建省中医药科学院、福建中医药大学附属康复医院)2023年度开放课题(FJOP2023-1)
更新日期/Last Update: 2023-12-10